GOODMAN JESSE
Insider CIK 1756929 · NTLA Director · PHGE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2026-06-09 | 2026-06-10 | 13,300 | — | $0 | 13,300 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2026-06-09 | 2026-06-10 | 9,200 | — | $0 | 33,559 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2025-07-01 | 2025-07-02 | 1,547 | $9.23 | $14.3K | 24,359 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2025-06-30 | 2025-07-02 | 1,547 | $9.56 | $14.8K | 25,906 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2025-06-11 | 2025-06-13 | 11,450 | — | $0 | 11,450 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2025-06-11 | 2025-06-13 | 8,000 | — | $0 | 27,453 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2025-04-14 | 2025-04-18 | 17,600 | — | $0 | 17,600 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2025-04-14 | 2025-04-21 | 17,600 | — | $0 | 17,600 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-07-11 | 2024-07-15 | 264,000 | — | $0 | 264,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2024-06-12 | 2024-06-14 | 11,515 | — | $0 | 11,515 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2024-06-12 | 2024-06-14 | 7,737 | — | $0 | 19,453 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2023-06-14 | 2023-06-16 | 6,473 | — | $0 | 6,473 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2023-06-14 | 2023-06-16 | 4,425 | — | $0 | 11,716 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2022-06-14 | 2022-06-16 | 7,688 | — | $0 | 7,688 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2022-06-14 | 2022-06-16 | 5,197 | — | $0 | 7,291 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2021-06-23 | 2021-06-25 | 3,382 | — | $0 | 3,382 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2021-06-23 | 2021-06-25 | 2,094 | — | $0 | 2,094 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2020-06-18 | 2020-06-19 | 19,000 | — | $0 | 19,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2019-05-21 | 2019-05-22 | 19,000 | — | $0 | 19,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2018-10-29 | 2018-10-31 | 38,000 | — | $0 | 38,000 | SEC↗ |